Your browser doesn't support javascript.
loading
The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia.
Laidou, Stamatia; Grigoriadis, Dionysios; Papanikolaou, Sofia; Foutadakis, Spyros; Ntoufa, Stavroula; Tsagiopoulou, Maria; Vatsellas, Giannis; Anagnostopoulos, Achilles; Kouvatsi, Anastasia; Stavroyianni, Niki; Psomopoulos, Fotis; Makris, Antonios M; Agelopoulos, Marios; Thanos, Dimitris; Chatzidimitriou, Anastasia; Papakonstantinou, Nikos; Stamatopoulos, Kostas.
Afiliação
  • Laidou S; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Grigoriadis D; Department of Genetics, Development, and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Papanikolaou S; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Foutadakis S; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Ntoufa S; Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece; and.
  • Tsagiopoulou M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Vatsellas G; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Anagnostopoulos A; Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece; and.
  • Kouvatsi A; Department of Hematology and Hematopoietic Cell Transplantation (HCT) Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Stavroyianni N; Department of Genetics, Development, and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Psomopoulos F; Department of Hematology and Hematopoietic Cell Transplantation (HCT) Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Makris AM; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Agelopoulos M; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Thanos D; Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece; and.
  • Chatzidimitriou A; Center of Basic Research, Biomedical Research Foundation, Academy of Athens, Athens, Greece; and.
  • Papakonstantinou N; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
Blood Adv ; 6(8): 2646-2656, 2022 04 26.
Article em En | MEDLINE | ID: mdl-35235952
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia